Claudia Büttner

Title: Claudia Büttner: Innovator in Antibody Research

Introduction

Claudia Büttner is a prominent inventor based in Schwetzingen, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of single-chain antibodies. Her work focuses on innovative solutions for diagnosing and treating prion diseases and cancer.

Latest Patents

Claudia Büttner holds 1 patent for her invention titled "Single-chain antibody acting against 37 kDa/67 kDa laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof." This patent describes single-chain antibodies that specifically recognize both the 37 kDa precursor form and the 67 kDa high-affinity form of the laminin receptor. These antibodies are crucial for developing pharmaceutical and diagnostic compositions aimed at addressing serious health conditions.

Career Highlights

Throughout her career, Claudia has worked with notable organizations such as Affimed Therapeutics and Ludwig Maximilians University Munich. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Claudia has collaborated with esteemed colleagues, including Stefan Knackmuss and Clémence Rey. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Claudia Büttner's work exemplifies the impact of innovative research in the medical field. Her contributions to antibody development are paving the way for new diagnostic and therapeutic approaches.